Ryde Group Ltd (RYDE) 1H26 Revenue Up 17%; Adj. EBITDA Loss Narrows 37%

Ryde Group Ltd (RYDE) signed an MOU with Dimension AI to explore a GPU-as-a-Service collaboration valued at up to $278 million over three years. The deal aligns with Ryde's Ryde 2.0 strategy to expand into AI computing services, combining Ryde's commercial capabilities with Dimension AI's AI infrastructure expertise. The actual commercial structure and financial arrangements are subject to further assessment and definitive agreements.

Ryde Group Ltd (RYDE) furnished an SEC Form 6-K — earnings release. Exhibit 99.3 Ryde Reports First Half 2026 Results SINGAPORE, October 8, 2026 – Ryde Group Ltd (NYSE American: RYDE) (“ Ryde ” or the “ Company ”), a leading technology platform for mobility and quick commerce headquartered in Singapore, today announced its unaudited financial res

Ryde Group, a Singapore-based ride-hailing firm listed on the NYSE, faces a shareholder petition and a class action lawsuit. The petition seeks a buyout or winding up, citing governance issues. The lawsuit accuses Ryde of a pump-and-dump scheme, alleging misleading statements to inflate share price. Ryde denies wrongdoing and plans to defend itself. Octava Fund, a major shareholder, alleges mismanagement and erosion of voting rights.

Ryde Group Ltd (NYSE American: RYDE) said it is rolling out RydePET XL, a larger 6-seater pet-friendly ride, and adding improved pet travel categories. The company added pet-type/carrier-vs-leash classification, expanded booking options for dogs, cats and other small pets, and enhanced driver trip visibility to improve matching accuracy, reduce cancellations and increase transparency in Singapore’s pet mobility market.

AMC Entertainment reported record quarterly revenue of $1.71 billion and adjusted EBITDA of $347.5 million, with shares up 7.32% to $3.52. CEO Adam Aron declared the company recovered, citing strong attendance and spending. However, AMC still faces debt and a stockholders' deficit. The company refinanced $3.97 billion in debt, pushing maturities to 2031 and 2033 but at higher interest rates. Shares outstanding increased 51.64% over a year.

Myriad Genetics (MYGN) has set a 2026 revenue outlook of $780M-$790M after divesting its Prenatal Health business for $210M. The company acknowledges challenges in Prenatal Health and reimbursement pressures in HCT, and is taking actions to address them.